Croda is today hosting investor seminar focusing on Life Sciences

Croda International Plc

Croda International (CRDA), the name behind high performance ingredients and technologies that are relied on by industries and consumers everywhere, is today hosting an Investor Seminar in London on its Life Sciences sector.

Senior members of the Group’s management team will provide a comprehensive overview of the sector, with a particular focus on the Health Care business. The Life Sciences sector offers compelling organic growth opportunities in both Crop and Health Care, alongside a continued ambition to selectively invest additional capital in acquisitions in adjacent technologies.

Presentation materials will be made available today at www.croda.com/investors. In addition, a video recording of the event will be made available later this week at the same address. No new material disclosures will be made during the event.

Share on:

Latest Company News

Croda posts stable Q1 2026 trading as Consumer Care offsets Life Sciences weakness

First-quarter sales were £431m, up 1% at constant currency against a strong prior-year comparator. Consumer Care growth, led by Beauty Actives and F&F, helped balance lower Crop Protection sales, while Croda reiterated its full-year 2026 outlook.

Croda International delivers 2025 earnings growth and targets higher margins by 2028

Croda reported 4.4% sales growth to £1.7bn in 2025, with adjusted operating profit up 7.9% at constant currency.

Croda International reports 6.5% sales growth in third quarter, outlook unchanged

Croda International reported third-quarter 2025 sales of £425 million, up 6.5% at constant currency, driven by strong performances in Beauty Actives, Fragrances and Flavours, and Crop Protection.

Croda H1 2025 sales Up 7% with adjusted profit before tax up 8%

Croda International delivered group sales of £855.8 m in the half year to 30 June 2025, up 7% at constant currency, with adjusted EBITDA rising 11% to £198.5 m and adjusted operating profit up 12% to £146.9 m.

Croda International Plc Q1 sales up 8%, outlook unchanged

Croda International Plc reports an 8% sales increase to £442m in Q1 2025, driven by growth across Life Sciences, Consumer Care, and Industrial Specialties.

Croda International reports Q3 sales growth and maintains FY24 profit outlook

Croda International Plc's Q3 2024 sales rose to £407m, up 5% year-on-year. Despite currency challenges, full-year profit outlook remains steady.

    Search